Full Text View
Tabular View
No Study Results Posted
Related Studies
Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis
This study has been completed.
Study NCT00473460   Information provided by Bayer
First Received: May 14, 2007   Last Updated: June 29, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lung Diseases
Bronchitis, Chronic
Additional conditions recognized in this trial
Acute Disease
Bronchitis
More general conditions related to this trial
Bronchial Diseases
Disease Attributes
Lung Diseases, Obstructive
Pathologic Processes
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
Avelox (Moxifloxacin, BAY12-8039)
Placebo
Additional drug interventions recognized in this trial
Moxifloxacin
More general drug interventions related to this trial
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services